Across TCGA pan-cancer cohorts, DPH3P1 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated DPH3P1 data layer.
The strongest signal is observed in small cell lung cancer (SCLC), where higher DPH3P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DPH3P1 expression acts as an unfavorable survival marker.
SCLC are the cancer types where DPH3P1 RNA most reproducibly stratifies survival.